We have previously shown, by different methodologies, an up-regulation of the cyclin-dependent kinase inhibitor p21 WAF1/Cip1 in COPD patients with muscle wasting [18]. This evidence concerns the gene CDKN1A and chronic obstructive pulmonary disease.